Clinical Trial Update: A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. [NA]

View source ↗

Summary

A multi-cohort clinical trial evaluating Efbemalenograstim Alfa Injection to prevent ANC reduction in solid tumor patients following immune-chemotherapy; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Solid Tumors

Drugs mentioned

• Efbemalenograstim Alfa Injection (efbemalenograstim alfa)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Solid Tumor Cancer, Chemotherapy Induced Neutropenia | NA | Status: NOT_YET_RECRUITING